Systemic Inflammatory Biomarkers as a Predictive Markers for Ovarian Cancer

Abstract

Systemic inflammatory biomarkers, particularly SII may aid in the predictive markers of early ovarian with diagnostic values nearly as good as CA125 (sensitivity 71.64% vs 75.97%). These biomarkers can serve as complementary predictive markes modalities for ovarian malignancy, especially when advanced tumor marker tests like CA125 are not available in remote areas.

Access to Document

Other files and links

• Link to publication in Scopus
• Open Access Version Available

Fingerprint